Captopril
NDC Package 50090-5964-3

11-digit billing NDC: 50090596403

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Captopril is tablets are contraindicated in patients who are hypersensitive to this product or any other angiotensin- converting enzyme inhibitor (e.g., a patient who has experienced angioedema during therapy with any other ACE inhibitor).Do not co-administer aliskiren with captopril tablets in patients with diabetes (see PRECAUTIONS: Drug Interactions).Captopril tablets are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Marketed by A-s Medication Solutions, this product is identified by NDC 50090-5964 and is authorized under FDA application ANDA074677.

Identification & Billing

NDC Package Code
50090-5964-3
Package Description
60 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
50090596403
RxNorm Crosswalk
RxCUI: 317173 - captopril 25 MG Oral Tablet

Clinical Specifications

Proprietary Name
Captopril
Dosage Form
-
Usage Information
Captopril tablets are contraindicated in patients who are hypersensitive to this product or any other angiotensin- converting enzyme inhibitor (e.g., a patient who has experienced angioedema during therapy with any other ACE inhibitor).Do not co-administer aliskiren with captopril tablets in patients with diabetes (see PRECAUTIONS: Drug Interactions).Captopril tablets are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer captopril tablets within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor (see PRECAUTIONS: Drug Interactions).

Regulatory & Marketing

Labeler Name
A-s Medication Solutions
FDA Application #
ANDA074677
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
08-20-2019
Listing Expiration
12-31-2023
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50090-5964-3 identifies a specific commercial package of 60 tablet in 1 bottle of Captopril, labeled by A-s Medication Solutions. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by A-s Medication Solutions on August 20, 2019. The current certification is valid through December 31, 2023.

How is this A-s Medication Solutions product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090596403. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50090-5964-3
11-Digit CMS (5-4-2)
50090-5964-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.